CLC and hypereosinophilic syndrome: ,4 These findings reflect eosinophil-mediated pathology and align with the notion of “luminal hypereosinophilic disease.”6 Galectin-10 crystallization with CLC formation is increasingly recognized not only as a marker of eosinophil activation but also as a contributor to mucus viscosity, impaired clearance, and persistent airway inflammation.3